Baird analyst Joel Beatty initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target Maximize Your ...

Noble metals such as platinum can make useful catalysts to accelerate chemical reactions, particularly hydrogenation (adding ...

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most ...

"Computing obeys the gas law," Gelsinger wrote, explaining that lowering costs will expand AI's reach rather than shrink the market. He also voiced support for open-source AI development ...

Disruption is a constant, but preparedness doesn’t have to be a guessing game. Klaus Jaeck of management consultancy Horváth ...

Tesla (TSLA) pledged a return to growth in 2025 on Wednesday after fourth quarter results disappointed, capping off a year that saw revenue rise just 1% while profits fell sharply from a year ago ...

On average, Catalyst charges fees on its funds that are in the highest quintile of similarly distributed funds. With the current market environment of fee compression, this is cause for concern ...

Investing.com -- UBS analysts warned in a note Wednesday that tariff concerns could become the next major risk catalyst for markets following Monday’s DeepSeek-driven AI sell-off. “With a measure of ...

Catalyst said Teva won't market its potential generic version of Firdapse in the U.S. any earlier than Feb. 25, 2035, unless "certain limited circumstances customarily included in these types of ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more ...

Considering these aspects of the Hydrodesulfurization Catalyst, the study of the Hydrodesulfurization Catalyst market becomes an important read. Hydrodesulfurization Catalyst is of critical importance ...